C74.00
Malignant neoplasm of cortex of unspecified adrenal gland
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the cortex of the unspecified adrenal gland, coded as ICD-10 C74.00, refers to a cancerous tumor that originates in the outer layer (cortex) of the adrenal gland. The adrenal glands are small, triangular-shaped organs located on top of each kidney, responsible for producing hormones like cortisol, aldosterone, and adrenaline. When these glands develop malignant tumors, it can impact hormone production and overall health, necessitating medical evaluation and treatment. This article offers an overview aimed at increasing understanding of this condition, including its causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal cell growth in the adrenal cortex Increased risk associated with inherited syndromes such as multiple endocrine neoplasia (MEN) type 1 and type 2 Environmental exposures, though specific links are limited, may contribute History of familial adrenal tumors or other endocrine cancers
Key Symptoms: Unexplained weight loss or gain Persistent abdominal or back pain Hormonal imbalance symptoms such as high blood pressure, muscle weakness, or unexpected hair growth Fainting or episodes of dizziness Enlargement of the affected adrenal gland detected during imaging tests Symptoms related to excess hormone production, including irregular menstrual periods or mood swings
Diagnostic & Treatment
Diagnosis Path: Diagnosis begins with detailed medical history and physical examination, emphasizing signs of hormone excess or deficiency. Imaging studies like computed tomography (CT) scans or magnetic resonance imaging (MRI) are critical for visualizing the adrenal glands and identifying tumors. Biopsy may be performed to confirm malignancy, although it is often avoided if imaging strongly suggests cancer due to potential risks. Laboratory tests measuring hormone levels, such as cortisol, aldosterone, and androgens, help determine if the tumor is functional (hormone-producing). Additional tests may include adrenal venous sampling and genetic testing to assist in diagnosis and treatment planning.
Treatment Protocols: Treatment options primarily include surgical removal of the affected adrenal gland (adrenalectomy), especially if the tumor is localized and operable. For advanced or metastatic cases, systemic therapies such as chemotherapy, targeted therapy, or immunotherapy may be recommended. Hormone therapy could also be necessary to manage hormonal imbalances caused by the tumor. Surgery is usually followed by close monitoring and additional treatments if needed. The specific approach depends on factors like tumor size, spread, patient health, and hormone activity. Multidisciplinary care involving endocrinologists, oncologists, and surgeons is essential for optimal management.
Clinical Advice & FAQs
Billing Guidance
Is C74.00 a billable ICD-10 code?
Yes, C74.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C74.00?
Clinical documentation must specify the nature of Malignant neoplasm of cortex of unspecified adrenal gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
